First Manhattan’s TG Therapeutics TGTX Stock Holding History

First Manhattan’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-5,000	Closed	-$50K	–	1477
2015 Q3	$50K	Buy	+5,000	New	+$74.5K	﹤0.01%	937

Other funds holding TGTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

First Manhattan's TGTX Position: Q4 2015 in Review

First Manhattan sold out of TG Therapeutics (TGTX) in Q4 2015, closing a stake of 5,000 shares — an estimated $50K sold.

First Manhattan first reported a position in TGTX in Q3 2015 and held it in 1 quarter. The position peaked at $50K in Q3 2015. 87 funds tracked by Wall St. Rank hold TGTX as of Q4 2015.

First Manhattan reported no remaining TG Therapeutics position as of Q4 2015 after selling out during the quarter.
First Manhattan sold 5,000 TG Therapeutics shares in Q4 2015, an estimated $50K.
First Manhattan first reported a position in TG Therapeutics in Q3 2015 and held it in 1 quarter.
First Manhattan's TG Therapeutics position peaked at $50K in Q3 2015.
87 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2015.

Based on First Manhattan's 13F filing for Q4 2015, filed 20 Jan 2016.